|
TMEM183A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.776300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.575100E-03 |
| Normal-vs-Stage2 |
7.250100E-02 |
| Normal-vs-Stage3 |
9.637400E-01 |
| Normal-vs-Stage4 |
3.950600E-01 |
| Stage1-vs-Stage2 |
6.843000E-01 |
| Stage1-vs-Stage3 |
3.381600E-02 |
| Stage1-vs-Stage4 |
1.099790E-01 |
| Stage2-vs-Stage3 |
1.774980E-01 |
| Stage2-vs-Stage4 |
1.517650E-01 |
| Stage3-vs-Stage4 |
4.220000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.739000E-03 |
| Normal-vs-AfricanAmerican |
1.585220E-01 |
| Normal-vs-Asian |
1.130240E-01 |
| Caucasian-vs-AfricanAmerican |
3.941200E-01 |
| Caucasian-vs-Asian |
7.394800E-01 |
| AfricanAmerican-vs-Asian |
4.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.477200E-03 |
| Normal-vs-Female |
3.284000E-01 |
| Male-vs-Female |
3.144100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.446400E-01 |
| Normal-vs-Extreme_Weight |
6.217900E-03 |
| Normal-vs-Obese |
4.507800E-02 |
| Normal-vs-Extreme_Obese |
3.979200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.468000E-01 |
| Normal_Weight-vs-Obese |
4.697400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.527200E-01 |
| Extreme_Weight-vs-Obese |
5.538000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.870200E-01 |
| Obese-vs-Extreme_Obese |
9.390000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.777630E-01 |
| Normal-vs-Age(41-60Yrs) |
6.188000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.052000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.538300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.281600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.020600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.420400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.148600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.722580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.042800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.253560E-02 |
| Normal-VS-Type2 PRCC |
6.534500E-02 |
| Normal-VS-KIRP CIMP |
9.377200E-01 |
| Normal-VS-Unclassified PRCC |
2.315000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.242600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.219590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.093000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.522000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.915400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.492800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.623300E-03 |
| Normal-vs-N1 |
2.233600E-01 |
| Normal-vs-N2 |
9.090400E-01 |
| N0-vs-N1 |
1.238290E-02 |
| N0-vs-N2 |
3.655800E-01 |
| N1-vs-N2 |
5.719600E-01 |
|
|
